Topics

Bayer's Nubeqa Posts Significant OS Data as it Fights for Market Share in Prostate Cancer

19:00 EST 30 Jan 2020 | BioSpace

The new data should give Bayer’s Nubeqa some energy to go after market share held by other drugs approved to treat prostate cancer, including Pfizer’s Xtandi.

Original Article: Bayer's Nubeqa Posts Significant OS Data as it Fights for Market Share in Prostate Cancer

NEXT ARTICLE

More From BioPortfolio on "Bayer's Nubeqa Posts Significant OS Data as it Fights for Market Share in Prostate Cancer"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...